01—Abstract
Summary
Summary of the 8-K filed October 28, 2024. Cited figures are marked; the original filing is the authoritative source.
Corpay, Inc. (CPAY) has filed an 8-K report detailing its preliminary third quarter 2024 financial results and providing an updated full-year 2024 adjusted net income per share outlook.
While specific financial figures for Q3 are not detailed in this 8-K beyond the press release announcement, investors should anticipate this information being available in the accompanying press release (Exhibit 99.1). Crucially, the filing also discloses a modification to the CEO's performance-based stock option award. Originally granted in 2021 with significant stock price hurdles for vesting by year-end 2024, the terms have been adjusted.
Specifically, 300,000 options from the second tranche have been cancelled, and the vesting condition for 550,000 options in the first tranche has been eased from ten consecutive trading days at or above $350a to three trading days at or above $350 by December 31, 2024. In exchange, the CEO has agreed to forgo any new equity grants in 2025. This adjustment was approved by the Compensation Committee.
02—Key points
Key Highlights
- Corpay announced preliminary Q3 2024 financial results and provided an updated full-year 2024 adjusted net income per share outlook via a press release attached as Exhibit 99.1.
- The CEO's performance stock option award, granted in 2021, has undergone modifications.
- 300,000 stock options from the second tranche of the CEO's award have been cancelled.
- The vesting condition for 550,000 stock options from the first tranche has been eased from 10 consecutive trading days to 3 trading days at or above $350 by December 31, 2024.
- The CEO has agreed to forfeit any new equity grants in 2025 as part of the option modification.
- The Compensation Committee, comprised of independent directors and advised by a compensation consultant, approved the modified award.
- The modifications were made following consideration of CEO performance, company strategic progress, and financial performance.
03—Questions
Frequently Asked Questions
Where can I find Corpay's preliminary Q3 2024 financial results and full-year outlook?
Corpay's preliminary Q3 2024 financial results and full-year 2024 adjusted net income per share outlook are detailed in a press release filed as Exhibit 99.1 to this 8-K filing.
What changes were made to the CEO's stock options?
The CEO's performance stock option award has been modified: 300,000 options from the second tranche were cancelled, and the vesting condition for 550,000 options in the first tranche was eased to require a closing stock price at or above $350 for 3 trading days (instead of 10 consecutive days) by December 31, 2024.
What did the CEO agree to in return for the stock option modification?
In exchange for the modified stock option award, the CEO has agreed to forgo any new equity grants in 2025.
Who approved the changes to the CEO's stock options?
The modified performance option award was approved by the Compensation Committee of Corpay, Inc., which is composed entirely of independent directors and received assistance from its independent compensation consultant.
04—Continue